DUBLIN, Ohio , Dec. 19, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2025 on January 30 , prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No... Read More

Next generation of the Kendall™ SCD Series delivers an all-in-one solution for deep vein thrombosis and pulmonary embolism prevention DUBLIN, Ohio , Nov. 20, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of its Kendall SCD SmartFlow™ Compression System, the next generation of the Kendall™ Compression Series offering an enhanced clinician and patient experience. Featuring clinically proven... Read More

Acquisition of a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy Acquisition of the Advanced Diabetes Supply Group, a leading national direct-to-patient provider of diabetes medical supplies, to accelerate Cardinal Health's at-Home Solutions growth strategy Company announces plan to hold Investor Day in... Read More

DUBLIN, Ohio , Nov. 5, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surplus. The dividend will be payable on January 15, 2025 to shareholders of record at the close of business on January 2, 2025 . About Cardinal Health Cardinal Health is a distributor of pharmaceuticals and specialty products; a... Read More

Revenue decreased 4% to $52.3 billion ; revenue increased 15% excluding the impact of the previously communicated large customer contract expiration GAAP 1 operating earnings were $568 million ; GAAP diluted EPS was $1.70 Non-GAAP operating earnings increased 12% to $625 million , driven by significant growth in Pharmaceutical and Specialty Solutions segment profit Non-GAAP diluted EPS increased 9% to $1.88 Fiscal year 2025... Read More

New facility in Boylston increases U.S. warehouse capacity and expands specialized handling capabilities DUBLIN, Ohio , Oct. 29, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the grand opening of its new distribution center in Boylston, Massachusetts , supporting its U.S. Medical Products and Distribution business. The facility provides healthcare customers in Massachusetts , New Hampshire , Rhode Island ,... Read More

DUBLIN, Ohio , Sept. 24, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2025 on November 1 , prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No... Read More

Transaction demonstrates Cardinal Health's continued strategic investment in specialty and oncology, underscores commitment to independent community healthcare providers Accelerates the development of Navista oncology practice alliance, adding more than 100 providers at more than 50 community-based sites delivering broad-reaching oncology and urology care across 10 states DUBLIN, Ohio , Sept. 20, 2024 /PRNewswire/ --... Read More

MELBOURNE, Australia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has selected Cardinal Health, Inc. (NYSE: CAH, Cardinal Health) as a commercial radiopharmaceutical distributor to supply finished unit doses of its PET 1 agent, Zircaix® 2 (TLX250-CDx) for the imaging of kidney cancer in the United States (U.S.), subject to regulatory approval. In... Read More

WASHINGTON and DUBLIN, Ohio , Sept. 10, 2024 /PRNewswire/ -- In observance of today's World Suicide Prevention Day, Children's Hospital Association (CHA), Cardinal Health (NYSE: CAH), and Zero Suicide Institute (ZSI) celebrate early success of the Preventing Youth Suicide Collaborative , a collaborative funded by the Cardinal Health Foundation, led by CHA, and informed by ZSI's prevention expertise. Since 2022, 30 children's... Read More

'Warehouse of the Future' to expand nationwide distribution network in support of home healthcare growth DUBLIN, Ohio , Aug. 28, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) officially announced today the recent opening of a new distribution center in Greenville, South Carolina dedicated solely to its at-Home Solutions business, expected to add roughly 200 jobs to the region over time. Cardinal Health at-Home Solutions... Read More

New facility opening in Walton Hills demonstrates ongoing commitment to increase U.S. warehouse capacity and modernize operations DUBLIN, Ohio , Aug. 21, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today its plans to open a new distribution center in Walton Hills, Ohio , supporting its U.S. Medical Products and Distribution business. The facility will integrate new technology solutions, deliver operational... Read More

DUBLIN, Ohio , Aug. 15, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surplus. The dividend will be payable on October 15, 2024 to shareholders of record at the close of business on October 1, 2024 . About Cardinal Health Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and... Read More

Fourth quarter revenue increased 12% to $59.9 billion Fourth quarter GAAP 1 operating earnings were $401 million and GAAP diluted EPS was $0.96 Fourth quarter non-GAAP operating earnings increased 14% to $605 million and non-GAAP diluted EPS increased 29% to $1.84 Fiscal Year 2024 operating cash flow and adjusted free cash flow reached all-time highs of $3.8 billion and $3.9 billion , respectively Fiscal year 2025 non-GAAP... Read More

DUBLIN, Ohio , July 23, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2024 on August 14 , prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor... Read More

DUBLIN, Ohio , May 7, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5056 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2024 to shareholders of record at the close of business on July 1, 2024 . About Cardinal Health Cardinal Health is a distributor of pharmaceuticals, a global... Read More

Revenue increased 9% to $54.9 billion GAAP 1 operating earnings were $367 million ; GAAP diluted EPS was $1.05 Non-GAAP operating earnings increased 10% to $666 million ; non-GAAP diluted EPS increased 20% to $2.08 Fiscal year 2024 non-GAAP EPS guidance 2 raised and narrowed to $7.30 to $7.40 , from $7.20 to $7.35 Company provides preliminary fiscal year 2025 non-GAAP EPS guidance of at least $7.50 DUBLIN, Ohio , May 2 ,... Read More

DUBLIN, Ohio , April 22, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024 , will not be renewed. The company reaffirmed its fiscal 2024 non-GAAP diluted EPS guidance of $7.20 to $7.35 . Despite the nonrenewal of the OptumRx contracts, the company also reiterated both its Pharmaceutical and Specialty Solutions... Read More

The Consumer Health Logistics Center will be located in Central Ohio and serve as a centralized hub for distribution of consumer health products COLUMBUS, Ohio , April 2, 2024 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) announced that construction has begun for a new 350,000 square-foot logistics center in Columbus, Ohio , that will serve as a centralized replenishment center for the distribution of over-the-counter... Read More

DUBLIN, Ohio , March 26, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2024 on May 2 , prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No access... Read More

DUBLIN, Ohio , March 15, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that the company has received approval by the Science Based Targets initiative (SBTi) for its near-term science-based greenhouse gas (GHG) emissions reduction targets. Targets are considered science-based if they align with what the latest climate science says is necessary to limit global warming to 1.5°C above pre-industrial levels.... Read More

Study reveals impact of dramatic increase in commercially available biosimilars and progress in the areas of patient accessibility and treatment affordability DUBLIN, Ohio , Feb. 29, 2024 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2024 Biosimilars Report: insights on a pivotal year of evolution and expansion, an analysis of key recent economic, competitive, legislative and societal developments in... Read More

DUBLIN, Ohio , Feb. 28, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors has elected Robert "Bob" Azelby as an independent director, effective March 1. Mr. Azelby joins the board with over 30 years of experience, including as a Chief Executive Officer and board member for large, matrixed organizations in the biopharmaceutical, oncology and other specialty industries. Mr. Azelby has... Read More

DUBLIN, Ohio , Feb. 6, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on April 15, 2024 to shareholders of record at the close of business on April 1, 2024 . About Cardinal Health Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and... Read More

DUBLIN, Ohio , Feb. 6, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today released its Fiscal 2023 Environmental, Social and Governance (ESG) Report , highlighting the company's work toward building a healthier, more equitable future. "At Cardinal Health, we approach ESG in a way that supports our business, positions us as a partner of choice for customers and suppliers, and ensures compliance with evolving regulatory... Read More

Revenue increased 12% to $57.4 billion GAAP 1 operating earnings were $482 million ; GAAP diluted EPS was $1.43 Non-GAAP operating earnings increased 20% to $562 million ; non-GAAP diluted EPS increased 38% to $1.82 Fiscal 2024 non-GAAP EPS guidance raised to $7.20 to $7.35 , from $6.75 to $7.00 2,3 Fiscal 2024 non-GAAP adjusted free cash flow guidance raised to ~$2.5 billion , from ~$2.0 billion Cardinal Health to acquire... Read More

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates platform for Cardinal Health expansion across specialty therapeutic areas Transaction enhances capabilities of Cardinal Health Specialty and supports ongoing build of Navista™ Network DUBLIN, Ohio , Jan. 31, 2024 /PRNewswire/ --... Read More

Progress achieved on company's ongoing business and portfolio review Completed review of growth businesses within the Medical Segment: investing in and further developing at-Home Solutions and OptiFreight ® Logistics as part of the company's portfolio for long-term growth and value creation Review of Global Medical Products and Distribution business continues, with focus on driving operational performance through the Medical... Read More

DUBLIN, Ohio , Jan. 2 , 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2024 on February 1 , prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No... Read More

DUBLIN, Ohio , Nov. 14, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on January 15, 2024 to shareholders of record at the close of business on January 2, 2024 . About Cardinal Health Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and... Read More

SmartGown™ EDGE is the first pocketed surgical gown designed to help maintain instrument sterility and accessibility. DUBLIN, Ohio , Nov. 9, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of its SmartGown™ EDGE Breathable Surgical Gown with ASSIST™ Instrument Pockets, created to provide surgical teams safe and convenient instrument access in the operating room. Exclusively available from... Read More

Revenue increased 10% to $54.8 billion GAAP 1 operating loss was $14 million and GAAP diluted EPS was $0.02 , driven by a Medical segment goodwill impairment Non-GAAP operating earnings increased 35% to $571 million , driven by significant increases in both Pharmaceutical segment profit and Medical segment profit; non-GAAP diluted EPS increased 44% to $1.73 Pharmaceutical segment profit grew 18% to $507 million and the... Read More

DUBLIN, Ohio , Oct. 18, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) has been named among the 100 Best Corporate Citizens, a prestigious annual ranking by 3BL Media that assesses the environmental, social and governance (ESG) transparency and performance of the 1,000 largest public companies in the U.S. "We're honored to be included among the 100 Best Corporate Citizens," said Cardinal Health CEO Jason Hollar. "Our ESG... Read More

The next generation in enteral feeding, Kangaroo OMNI™ delivers nutrition and hydration from hospital to home. DUBLIN, Ohio , Sept. 28, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of its Kangaroo OMNI™ Enteral Feeding Pump, designed to help provide enteral feeding patients with more options to meet their personalized needs throughout their enteral feeding journey. Kangaroo OMNI™ is the... Read More

DUBLIN, Ohio , Sept. 26, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2024 on November 3 , prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No... Read More

Cardinal Health Foundation will invest $1.7M to help 14 children's hospitals nationwide prevent youth suicide. DUBLIN, Ohio , Sept. 13, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) in partnership with Children's Hospitals Association (CHA) and the Zero Suicide Institute (ZSI) announced today the second round of grant recipients for the Preventing Youth Suicide: A Cardinal Health Foundation National Collaborative. The... Read More

The NTrainer™ System 2.0 is the only FDA Class II biofeedback device designed to help newborns and infants born prematurely develop their non-nutritive sucking skills needed for independent oral feeding. DUBLIN, Ohio , Aug. 30, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the launch of its next generation NTrainer™ System 2.0, a medical device designed to help premature and newborn infants develop the... Read More

Fourth quarter revenue increased 13% to $53.5 billion Fourth quarter GAAP 1 operating earnings were $137 million and GAAP diluted loss per share was $0.25 Fourth quarter non-GAAP operating earnings increased 24% to $560 million and non-GAAP diluted EPS increased 48% to $1.55 Fourth quarter Pharmaceutical segment profit increased 12% to $504 million and Medical segment profit increased to $82 million Generated both operating... Read More

DUBLIN, Ohio , Aug. 9, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on October 15, 2023 to shareholders of record at the close of business on October 3, 2023 . About Cardinal Health Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and... Read More

DUBLIN, Ohio , July 5, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2023 on August 15 , prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations... Read More

New facility is the largest at-Home Solutions has built to date, set to accommodate continued business and home healthcare industry growth DUBLIN, Ohio , June 15, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today its plans to build a new distribution center in the Greenville, South Carolina , area, to support its at-Home Solutions business, a market-leading home healthcare medical supplies provider serving... Read More

Narrowing fiscal year 2023 non-GAAP diluted EPS guidance to $5.65 to $5.80 , from $5.60 to $5.80 (13% growth at the mid-point) 1 Providing preliminary fiscal year 2024 non-GAAP diluted EPS guidance of $6.45 to $6.70 (15% growth at the mid-points) Providing long-term financial targets reflecting 12% to 14% growth of non-GAAP diluted EPS (3-year CAGR) 2 Raising long-term financial target for Pharmaceutical segment profit to 4%... Read More

Cardinal Health's Outcomes™ business will combine with Transaction Data Systems to offer improved patient engagement and clinical pharmacy solutions, expanding connections between payers and pharma to its nationwide pharmacy network DUBLIN, Ohio , June 5, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced it has signed a definitive agreement to contribute its Outcomes™ business to Transaction Data Systems... Read More

DUBLIN, Ohio and SAN FRANCISCO , May 31, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today launched modern payment solutions, powered by Square , to help independent pharmacies increase operational efficiency, stay current with customer payment preferences, and access integrated software tools for their business. The collaboration with Square allows Cardinal Health to offer its independent pharmacy customers access to... Read More

DUBLIN, Ohio , May 11, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to the Company's quarterly dividend, to $0.5006 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2023 to shareholders of record at the close of business on July 3, 2023 . About Cardinal Health Cardinal Health is a distributor of pharmaceuticals, a... Read More

New facility to utilize state-of-the-art robotics technology to drive efficiencies and accuracy TORONTO , May 10, 2023 /CNW/ -- Cardinal Health Canada (NYSE: CAH) announced today plans to open a new distribution center in the Greater Toronto Area (GTA), expanding its distribution footprint to nine strategic locations to better meet the medical and surgical product demands of the Canadian healthcare system. The 163,000... Read More

Revenue increased 13% to $50.5 billion GAAP 1 operating earnings were $572 million ; GAAP diluted EPS was $1.34 Non-GAAP operating earnings increased 11% to $606 million ; non-GAAP diluted EPS increased 20% to $1.74 Fiscal year 2023 non-GAAP EPS guidance raised and narrowed to $5.60 to $5.80 , from $5.20 to $5.50 Fiscal year 2023 adjusted free cash flow guidance raised and narrowed to $2.0 to $2.3 billion , from $1.5 to $2.0... Read More

DUBLIN, Ohio , April 19, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the launch of the first-of-its-kind Stray Away™ hair management drape for more efficient surgical procedure preparation. The Stray Away™ drape is specifically designed and manufactured by Cardinal Health to help minimize hair from obstructing the surgical area and to improve patient preparation time and experience. Pre-operative... Read More

The new facilities represent Cardinal Health's ongoing commitment to servicing customers, warehousing modernization and growing the local economy DUBLIN, Ohio , April 17, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it is celebrating the opening of two new distribution centers in Central Ohio this month. Both facilities will support the company's Medical Segment, focusing on its U.S. Medical Products... Read More

DUBLIN, Ohio , March 30, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2023 on May 4 , prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No access... Read More

NEWPORT NEWS, Va. , March 16, 2023 /PRNewswire/ -- Swisslog, a leading provider of best-in-class warehouse automation and software, has announced that Cardinal Health (NYSE: CAH) will install a Swisslog Automation Solution within its new at-Home Solutions distribution center in Grove City, Ohio . The facility is part of the... Read More

DUBLIN, Ohio , March 6, 2023 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced its collaboration with Signify Health (NYSE:SGFY) to offer in-home clinical and medication management services through its Outcomes™ business. This collaboration will help reduce costs and eliminate gaps in care for more than 2.3 million members nationwide to support their treatment journey from prescription to pharmacy to home. Studies... Read More

ST. PETERSBURG, Fla., Feb. 16, 2023 (GLOBE NEWSWIRE) -- RxLive , today announced a collaboration with Outcomes , a Cardinal Health (NYSE: CAH) company, to improve data sharing and reduce communication gaps between hospitals, physicians and pharmacies. Hospital readmissions cost the U.S. healthcare system billions of dollars each year, and recent studies show that approximately a quarter of potentially avoidable readmissions... Read More

DUBLIN, Ohio , Jan. 3, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2023 on February 2 , prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No... Read More

DUBLIN, Ohio , Dec. 19, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) and its board of directors announced today that Aaron Alt will become the company's new chief financial officer (CFO). Alt will succeed interim CFO, Trish English and will report to CEO, Jason Hollar , as a member of the company's Executive Committee... Read More

DUBLIN, Ohio , Dec. 9, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) released today its latest edition of Oncology Insights , a biannual, research-based report from Cardinal Health . Featuring perspectives from nearly 200 oncologists nationwide, the 12th edition of Oncology Insights focuses on patient diversity, health equity in oncology, care management and symptom monitoring. The research revealed that 80% of... Read More